Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Andrew Bird

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|December 4, 2021
Food Insecurity in the Food Allergic Population: A Work Group Report of the AAAAI Adverse Reactions to Foods CommitteeJodi Shroba, Rajeshree Das, Lucy Bilaver, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 18, 2024
Omalizumab Implementation in Practice: Lessons Learned From the OUtMATCH StudyBrian P Vickery, J Andrew Bird, R Sharon Chinthrajah, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 27, 2012
Safe administration of the seasonal trivalent influenza vaccine to children with severe egg allergyMatthew J Greenhawt, Jonathan M Spergel, Matthew A Rank, et al.
The Journal of Allergy and Clinical Immunology|November 24, 2024
The use and implementation of omalizumab as food allergy treatment: Consensus-based guidance and Work Group Report of the Adverse Reactions to Foods Committee of the American Academy of Allergy, Asthma & ImmunologyAikaterini Anagnostou, J Andrew Bird, Sharon Chinthrajah, et al.
The Journal of Allergy and Clinical Immunology. Global|March 17, 2025
Multicenter food protein-induced enterocolitis syndrome (FPIES) data collection: Leveraging a REDCap FPIES registry for improved clinical outcomesAnkona Banerjee, J Andrew Bird, Amy M Scurlock, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 3, 2017
Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical TrialJ Andrew Bird, Jonathan M Spergel, Stacie M Jones, et al.
The Journal of Pediatrics|July 29, 2024
Awareness and Application of United States Food Allergy Prevention Guidelines Among Pediatricians and Other CliniciansJulie Wang, J Andrew Bird, Kelly Cleary, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|November 19, 2024
AAAAI-EAACI PRACTALL: Standardizing oral food challenges-2024 UpdateHugh A Sampson, Stefania Arasi, Henry T Bahnson, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 28, 2023
Retail Food Equivalents for Post-Oral Immunotherapy Dosing in the Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen Oral Immunotherapy in Food-Allergic Children and Adults (OUtMATCH) Clinical TrialMarion Groetch, Kim Mudd, Margaret Woch, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 18, 2020
Conducting an Oral Food Challenge: An Update to the 2009 Adverse Reactions to Foods Committee Work Group ReportJ Andrew Bird, Stephanie Leonard, Marion Groetch, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
The Journal of Allergy and Clinical Immunology. in Practice|December 4, 2021
Food Insecurity in the Food Allergic Population: A Work Group Report of the AAAAI Adverse Reactions to Foods CommitteeJodi Shroba, Rajeshree Das, Lucy Bilaver, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 18, 2024
Omalizumab Implementation in Practice: Lessons Learned From the OUtMATCH StudyBrian P Vickery, J Andrew Bird, R Sharon Chinthrajah, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 27, 2012
Safe administration of the seasonal trivalent influenza vaccine to children with severe egg allergyMatthew J Greenhawt, Jonathan M Spergel, Matthew A Rank, et al.
The Journal of Allergy and Clinical Immunology|November 24, 2024
The use and implementation of omalizumab as food allergy treatment: Consensus-based guidance and Work Group Report of the Adverse Reactions to Foods Committee of the American Academy of Allergy, Asthma & ImmunologyAikaterini Anagnostou, J Andrew Bird, Sharon Chinthrajah, et al.
The Journal of Allergy and Clinical Immunology. Global|March 17, 2025
Multicenter food protein-induced enterocolitis syndrome (FPIES) data collection: Leveraging a REDCap FPIES registry for improved clinical outcomesAnkona Banerjee, J Andrew Bird, Amy M Scurlock, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 3, 2017
Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical TrialJ Andrew Bird, Jonathan M Spergel, Stacie M Jones, et al.
The Journal of Pediatrics|July 29, 2024
Awareness and Application of United States Food Allergy Prevention Guidelines Among Pediatricians and Other CliniciansJulie Wang, J Andrew Bird, Kelly Cleary, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|November 19, 2024
AAAAI-EAACI PRACTALL: Standardizing oral food challenges-2024 UpdateHugh A Sampson, Stefania Arasi, Henry T Bahnson, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 28, 2023
Retail Food Equivalents for Post-Oral Immunotherapy Dosing in the Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen Oral Immunotherapy in Food-Allergic Children and Adults (OUtMATCH) Clinical TrialMarion Groetch, Kim Mudd, Margaret Woch, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 18, 2020
Conducting an Oral Food Challenge: An Update to the 2009 Adverse Reactions to Foods Committee Work Group ReportJ Andrew Bird, Stephanie Leonard, Marion Groetch, et al.
Pageof 10